Background: Hajj is the largest annual mass gathering; the risk of respiratory infection is high.
Introduction
Hajj is one of the five basic tenets of Islam. Every practising, financially and physically capable Muslim is required to perform Hajj at least once in their lifetime. Each year up to 3 million people from more than 180 countries assemble in Mecca, Saudi Arabia to perform Hajj pilgrimage. Severe crowding, shared accommodation, reduced personal hygiene and environmental pollution at Hajj may collectively lead to increased transmission of respiratory viruses, notably influenza. [1] [2] [3] Several months before each Hajj, the Saudi Arabian Ministry of Health (MoH) publishes health recommendations including vaccination requirements for pilgrims. 4 Influenza vaccine has been recommended since 2005, particularly for people 'at-risk' of severe complications, defined as those aged ≥65 years old and/or people with pre-existing medical conditions such as chronic lung, heart, liver, kidney, neuromuscular, metabolic or immune-compromising conditions. 4, 5 Despite this yearly recommendation, influenza vaccine uptake rate among Hajj pilgrims has varied by country and by year (see Table 1 ). [6] [7] [8] [9] [10] [11] [12] [13] There are no comprehensive official data on influenza vaccination rate among Australian Hajj pilgrims or other travellers. A prospective study that assessed the incidence and risk factors for acute respiratory illnesses and influenza infections among Australian travellers between August 2007 and January 2010, reported only 49% influenza vaccine uptake prior to their trip to Asia, and actually just 56% travellers admitted receiving the vaccine in the 3 years before travel. 14 In a subsequent survey conducted among the students of the University of New South Wales, Sydney, Australia in 2010, intending to travel abroad, only 25% students reported 'ever'
receiving an influenza vaccine. 15 To this end, we have assessed the uptake of influenza vaccine, and examined the attitudes and barriers to, and perception of vaccination among Australian pilgrims who attended Hajj pilgrimage in 2 consecutive years, 2011 and 2012.
Method

Study participants
The study surveyed a convenience sample of Australian pilgrims who assembled for Hajj 
Results
The 2011 Survey
Demographics
In 2011, about 4,200 Australian pilgrims assembled for Hajj; 442 (11%) were serially approached and 431 (98%) completed the questionnaire (Fig. 1 Half of the participants (n=217) were from New South Wales (NSW), a third (n=143) were from Victoria and the rest 17% (n=71) were from other Australian states and territories, reflecting a representative sample of Muslims based on their place of residence in Australia. 16 Saudi Arabian Hajj regulations require that every Hajj pilgrim must travel to Mecca through a registered tour group. Our study participants travelled to Hajj through 16 different tour groups.
The largest proportion of the respondents belonged to tour group 'A' (n=104, 24%) and the rest belonged to one of 15 'other tour groups' ranging in size from 1 to 81.
Ninety one pilgrims (21%) were 'at-risk' (n=61, 67% with chronic medical conditions, n=12, 13% aged ≥65 years and n=18, 20% with both). Fifty one (56%) of them were male and 38 (42%) female; gender was unknown for 2 (2%).
Vaccine uptake
Of 431 pilgrims, 278 (65%) reported receiving influenza vaccine in 2011. The vaccination rate in pilgrims from NSW was significantly lower than those from the other states and they were younger (mean age: 40 [SD 15] versus 44 [SD 14] years, p < 0.01). However, they had a similar proportion of pilgrims with risk conditions (19% versus 23%, p = 0.37). Uptake rates by those aged ≥65 years from NSW and from other states were similar (73%).
The vaccination rates by age groups, 'at-risk' conditions and tour groups are shown in Table 2 .
'Not at-risk' females had higher vaccination rate compared to 'not at-risk' males (73% versus 56%, p < 0.01), but for the 'at-risk' groups (76% versus 69%, p = 0.43) the difference was not significant.
Of the 278 vaccinated pilgrims in 2011, 244 (88%) reported receiving the vaccine from their GPs, 13 (5%) from hospitals, 11 (4%) at their work place, 7 (3%) at other places including travel clinics and the remaining 3 (1%) did not specify the place of vaccination.
Of 153 non-vaccinated pilgrims, 142 (93%) provided reasons for not being vaccinated; the reasons are listed in Table 3 .
One hundred and forty two (33%) reported receiving the monovalent pandemic vaccine in 2009, whereas 268 (62%) did not, and the remaining 21 (5%) Hajjis did not answer the question. One 
The 2012 Survey
Demographics
In 2012, about 4,000 Australian pilgrims congregated at Hajj; 553 (14%) of these were approached and 535 (97%) completed the questionnaires (Fig. 1) , 334 (62%) were male, 182 (34%) female and in 19 (4%) gender was not stated. Age or date of birth was obtained from 506 (95%) pilgrims aged between 12 and 83 (median 43) years.
The distribution of residency in this survey was comparable to the 2011 survey with 40% (n= 216) participants from NSW, 36% (n=192) from Victoria and the rest 25% (n=133) from other Australian states and territories. Participants travelled to the 2012 Hajj through 13 different tour groups. As in 2011, the largest proportion of the participants were from tour group 'A' (n=111, 21%) and the rest belonged to one of 12 'other tour groups'.
One hundred pilgrims (19%) were considered 'at-risk' due to the presence of one or more indications for vaccination including chronic medical conditions (n=83, 83%), age ≥65 years (n=17, 17%) or both (n=16, 16%); 62 (62%) were male and 37 (37%) female and the gender of one pilgrims 'at-risk' (1%) was unknown.
Vaccine uptake
Of 535 participants, 476 (89%) reported receiving influenza vaccine in 2012, 42 (8%) did not receive the vaccine and in 17 (3%) vaccination history was not stated. The uptake rate was similar in both genders, across the states and tour groups ( Table 2) .
Of 42 non-vaccinated pilgrims, 32 (76%) provided reasons for not being vaccinated; the reasons are listed in Table 3 . Recommendation of the Hajj tour group leader was the commonest reason (65%) for pilgrims' vaccine uptake; other reasons are listed in Table 4 .
Discussion
We have shown evidence for a much greater uptake of influenza vaccine among Australian Hajj travellers received influenza vaccine for their trip and 11% received the vaccine in previous years. However, specific data for Australian travellers were not shown. 15 Specific data on influenza vaccination uptake among Australian travellers to Asia and student travellers to international destinations show that the uptake rate is generally between 25% and 49%.
14 However, vaccine uptake among Australian travellers and Hajj pilgrims (found in this survey) is better than for some other developed countries such as the UK where a recent survey found that only 20.8% travellers reported having influenza vaccine over the preceding 5 years. 22 In our 2011 survey, pilgrims who had received influenza vaccine previously had a higher vaccine uptake. Systematic reviews have consistently confirmed that receiving a prior seasonal influenza vaccination is an important determinant of both pandemic and seasonal influenza vaccination. [23] [24] [25] This fact was examined by Shahrabani and Benzion through the use of an analytical model based on four dependent variables: beliefs about susceptibility to contracting influenza, severity of illness, perceived benefits of the vaccine in preventing influenza, and perceived barriers to getting vaccinated. The investigators found out that individuals who had 'flu shots' in the past perceived higher levels of benefits from the vaccine and lower barriers to getting the vaccine than those who had not been vaccinated, while those who had had influenza infection over the previous 2 years exhibited higher levels of perceived susceptibility and lower levels of perceived benefits from the vaccine. Health beliefs regarding the influenza vaccine and past illness seem to influence vaccine acceptance, but not always predictably. 26 This helps explain why pilgrims receiving influenza vaccine previously had a significantly higher uptake than those who missed it.
Misconceptions were common among Hajj pilgrims who did not receive the influenza vaccine. pandemic influenza was not fatal and there were toxic preservatives in the vaccine. 28 In a previous survey conducted among Asia-Pacific travellers including Australians, 27% believed that they were not at risk of influenza and another 14% thought that influenza vaccine was not important. 29 A USA survey also confirms that many travellers avoid influenza vaccination due to misperceptions such as thinking that they do not need the vaccine and fearing of being ill from the vaccine or of needles etc. 30 It is reassuring that in our study no Hajj pilgrim refused the vaccine on 'religious grounds'. However, this study indicated that recommendations of religious leaders like Imams and tour group leaders were important in enhancing the uptake of influenza vaccine among pilgrims. A study in the UK showed that religious leaders-such as Imams and Quran teachers are "important drivers of health promotion measures". 31 In 2011 females had significantly higher vaccine uptake than males which corresponds with Australian national influenza vaccination data. 27 A Dutch study involving Hajj pilgrims in 2001
to 2009 showed similar gender difference for diphtheria, tetanus and pertussis (DTP) vaccine uptake. 32 However, a gender difference was not observed in the 2012 survey, neither were there differences across tour groups or Australian states when many more people accepted vaccination.
Moreover, there were differences in vaccination rates across tour groups and Australian states which were not found in the 2012 survey, implying that such a difference was peculiar to the year 2011 only, and the differences disappeared when the overall vaccination rate improved in
2012.
A strength of this study is that it is the first to investigate influenza vaccine uptake among Australian Hajj pilgrims and one of the few studies to assess vaccine uptake among Australian travellers, and the study is representative of Muslims throughout Australia. Surveys were completed and collected within 30 minutes after Hajjis had opportunity to clarify questions; we achieved a very high (97%) response rate. However, the study has some limitations: being an anonymous survey, GP vaccination records could not be used for verification of vaccination or co-morbid conditions. Additionally, some data were missing as some questionnaires were only partially completed (for instance about 3.5% pilgrims did not disclose their age and gender).
Level of education and occupation could influence pilgrims' perception about influenza vaccine, but these data were not collected. Finally, our findings may not be generalisable to ordinary travellers due to the distinctive characteristics of Hajj pilgrims and the religious nature of the event.
In summary, this survey shows that many more Australian pilgrims (89%) received influenza Believing that the vaccine doesn't work 10 (7) 2 (5) 0.7
Thought that vaccine gives flu 9 (6) 2 (5) 0.8
They had to pay 9 (6) 1 (2) 0.4
They took it in previous years year 8 ( Recommended by a friend 55 (12) To protect family 47 (10) Vaccine is offered at workplace 43 (9) Working with vulnerable people 31 (7) Considering themselves "at-risk" 17 (4)
Because of travel to Hajj 15
Other reasons 12 (3) *Most participants reported more than one reason.
